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ABSTRACT 
Rationale: Several human and experimental studies have shown that early life adverse 
events can shape physical and mental health in adulthood. Stress or elevated levels of 
glucocorticoids (GCs) during critical periods of development seem to contribute for the 
appearance of neurospyschiatric conditions such as anxiety and depression, albeit the 
underlying mechanisms remain to be fully elucidated. 
Objectives: The aim of the present study was to determine the long-term effect of prenatal 
erxposure to dexamethasone- DEX (synthetic GC widely used in clinics) in fear and anxious 
behavior and identify the neurochemical, morphological and molecular correlates. 
Results: Prenatal exposure to DEX triggers a hyperanxious phenotype and altered fear 
behavior in adulthood. These behavioral traits were correlated with increased volume of the 
bed nucleus of the stria terminalis (BNST), particularly the anteromedial subivision which 
presented increased dendritic length; in parallel, we found an increased expression of 
synapsin and NCAM in the BNST of these animals. Remarkably, DEX effects were opposite in 
the amygdala, as this region presented reduced volume due to significant dendritic atrophy. 
Albeit no differences were found in dopamine and its metabolite levels in the BNST, this 
neurotransmitter was substantially reduced in the amygdala, which also presented an up-
regulation of dopamine receptor 2. 
Conclusions: Altogether our results show that in utero DEX exposure can modulate anxiety 
and fear behavior in parallel with significant morphological, neurochemical and molecular 
changes; importantly, GCs seem to differentially affect distinct brain regions involved in this 
type of behaviors. 
 
 
KEYWORDS:  anxiety; fear; amygdala; BNST; stereology; neurodevelopment; corticosteroids 
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INTRODUCTION 
Since the initial evidence on its benefit in the prevention of respiratory distress syndrome in 
preterm infants (Liggins and Howie, 1972), antenatal glucocorticoids (GC) have gained wide 
clinical use in the enhancement of fetal lung maturation in pregnancies at risk of preterm 
delivery (Crane et al., 2003; Crowley, 1995; NIH, 1995). In fact, accumulating evidence shows 
a substantial decrease in neonatal morbidity and mortality, which strongly supported the 
recommendations for its clinical use (Hofmeyr, 2009; NIH, 1995). Additionally, antenatal GCs 
have been use to treat other conditions such as congenital adrenal hyperplasia (Speiser et 
al., 2010).  
GCs act predominantly through intracellular receptors which control the transcription of GC-
responsive target genes (Matthews, 2001); Sousa et al., 2008). While endogenous GCs 
(corticosterone in rats and cortisone in humans), at basal levels, display higher affinity to the 
mineralocorticoid receptors (MR), leaving glucocorticoid receptors (GR) receptors largely 
unoccupied (De Kloet et al., 1998), synthetic GCs such as dexamethasone (DEX) can readily 
cross the placenta and bind almost exclusively to GR (Reul et al., 1987). GRs can also be 
activated when endogenous GC secretion is elevated and this chronic activation is noxious 
for both the periphery and the brain (Sapolsky, 1999). One relevant finding is that despite 
both being efficacious in preventing respiratory distress syndrome (Crowley, 2000), synthetic 
GCs effects seem to be more deleterious than endogenous GCs (Oliveira et al., 2006).  
While the use of antenatal GCs triggers long-term gains in several clinical conditions, 
evidence is also revealing the detrimental effects of antenatal exposure to these hormones; 
in fact, it is now established a correlation between GC exposure in early life with several 
metabolic (Barker, 1995; Lindsay et al., 1996) and emotional and mood disorders in both 
animal models and humans in adulthood (Mesquita et al., 2009; Weinstock, 2001). These so-
called “programming effects” of GCs may result from endocrine, morphological, 
neurochemical and molecular changes in specific brain regions; as examples, we have shown 
that antenatal exposure to DEX significantly changes the mesolimbic circuit (Leao et al., 
2007) while others have shown deleterious effects in the prefrontal cortex (Diaz Heijtz et al., 
2010), amygdala and hypothalamus (Nagano et al., 2008). Importantly, previous studies from 
our lab have shown that antenatal exposure to GCs induces a hyperemotional phenotype in 
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adulthood (Oliveira et al., 2006). Given the established the role of the amygdala and bed 
nucleus of stria terminalis (BNST) in fear and anxiety (Davis, 1992a, b, 1998, 2006), herein we 
decided to perform an extensive morphological and molecular analysis of these brain 
regions in adult animals exposed to antenatal DEX and to search for correlations with fear 
and anxiety behaviors. 
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MATERIALS AND METHODS 
Animals and Treatments 
Experiments were conducted in accordance with European Union regulations (Directive 
86/609/EEC) and National Institutes of Health guidelines on animal care and 
experimentation. 
Fourteen pregnant Wistar rats (Charles River Laboratories, Barcelona, Spain) were 
individually housed under standard laboratory conditions (room temperature 22ºC; 12/12h 
light/dark cycle; food and water ad libitum). Subcutaneous injections of dexamethasone 
(DEX, 1 mg/kg; N=7) or vehicle (CONT, 1 mL/kg; N=7) were administered on embryonic (ED) 
18 and 19 of pregnancy, as previously described (Oliveira et al., 2006; Oliveira et al., 2011). 
Weaning was carried out at postnatal day 21; male offspring was randomly distributed in 
groups of two animals per cage according to treatment. Ten males from 4 to 5 different 
litters of each treatment were tested for behavior at 3 months age. 
Elevated plus maze 
The elevated plus maze test, used to assess the degree of anxiousness, was performed on a 
black polypropylene plus-shaped platform elevated 72.4 cm above the floor (ENV-560; 
MedAssociates Inc, St Albans, VT, USA). The maze consisted of two open arms (50.8 X 10.2 
cm) and two closed arms (50.8 X 10.2 X 40.6 cm). Animals were tested over a period of 5 
minutes, under bright white light. The number of entries into each of the arms and the time 
spent therein were recorded using a system of infrared photobeams. Data were processed 
to obtain the ratio of time spent in the open arms versus total time and the number of 
entries into each arm of the maze. 
 
Acoustic startle as a function of stimulus intensity 
Acoustic startle reflex was measured in a startle response system (SR-LAB, San Diego 
Instruments, San Diego, CA, USA). The apparatus consisted of a non-restrictive Plexiglas 
cylinder (inner diameter 8.8 cm, length 22.2 cm), mounted on a Plexiglas platform and 
placed in a ventilated, sound-attenuated chamber. A piezoelectric element detected cylinder 
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movements. Background white noise (intensity 63 dB) was used to minimize the impact of 
external acoustic stimuli.  
Animals were habituated to the apparatus (5 minutes daily) for 2 days before testing. In the 
trial day, following 5 minutes acclimatization to the chamber, rats were presented 5 baseline 
startle stimuli (50 ms pulse of white noise at 120 dB) at a 30 s inter-stimulus interval, in 
order to become familiarized with the startle stimuli. Then, 60 startle stimuli were randomly 
presented (50 ms duration and variable intensity between 70 and 120 dB at 10 dB 
increments). Startle magnitude was assessed at 1 ms intervals, during the 200 ms period 
following stimulus. Chambers were cleaned between tests (70% ethanol and water) in order 
to remove olfactory cues.  
 
Prepulse inhibition 
The test lasted 20 minutes, following a 5 minutes acclimatization period. A white background 
noise (70 dB) was provided. Following five introductory 120 dB startle trials (noise lasting 40 
ms), a total of 35 test trials were pseudo-randomly delivered as follows: a) five trials with 
background noise only, b) 10 startle trials of 120 dB and c) five prepulses of each of four 
different intensities preceding a startle trial. Prepulse intensitites of 2, 4, 8 and 16 dB above 
the background noise level lasted 20 ms and preceded the 120 dB startle presentation in 100 
ms. Intertrial intervals ranged from 10 to 20 seconds. The average startle response (AVG) 
was assessed in the 100 ms period following the onset of the startle stimulus presentation. 
The mean AVG for the ten 120dB startle trials was employed in the formula used to assess 
the percentage of reduction in AVG compared to startle trials alone: % PPI = 100 X [1-(AVG 
at prepulse plus startle trial)/(AVG at startle trial)].  
 
Fear-potentiated startle 
A stainless steel grid was adapted to the floor of the testing chamber, through which an 
electric current could be passed under software control. Following a 5 minutes 
acclimatization period, 20 light-shock pairings were presented at 30 seconds intervals. The 
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shock (0.6 mA) was presented during the last 500 ms of the 5 s light pulse (3 watt 
incandescent light bulb). Following conditioning, animals were returned to their home cages. 
On the testing day, the steel grid used during conditioning, was maintained. After 5 minutes 
acclimatization, 20 baseline startle stimuli were presented. Startles were measured. Then, 
animals were randomly presented 10 startle stimuli (intensity 120 dB, duration 50 ms), five 
of them during the last 50 ms of the delivery of a 5 s luminous conditioned stimulus (CS).  
 
Histological procedures 
Following behavioral assessment, 8 male animals (derived from 4 to 5 different litters) of 
each group were placed under deep pentobarbital anesthesia and transcardially perfused 
with either 4% paraformaldehyde solution (N=4) or 0.9% saline (N=4). 
Brains from the former set of subjects were embedded in glycolmethacrylate (Tecnovit 
7100; Heraeus Kulzer, Werheim, Germany) and 30 µm coronal sections were obtained by 
microtome (Cerqueira et al., 2005). These were placed on a gelatinized slide, stained with 
Giemsa, mounted with Entellan (Merck, Darmstadt, Germany) and coverslipped. Shrinkage 
factor was calculated according to previous studies (Madeira et al., 1990). 
Brains from animals perfused with 0.9% saline were processed for Golgi-Cox staining as 
previously described (Gibb and Kolb, 1998); details are given in supplementary material. 
 
Regional boundaries 
We analyzed stereological parameters in three regions of the amygdaloid complex, namely 
the basolateral anterior (BLa), lateral (La) and central (CeA), as previously outlined (Paxinos 
and Watson, 2005). CeA and La nuclei were differentiated using prior definitions (De Omlos 
et al., 2004) and the BLa division was distinguished from surrounding areas on the basis of 
cell size and staining intensity (De Omlos et al., 2004; Krettek and Price, 1978). In accordance 
with a recent revision of anatomical and projection studies of the BNST (Dong et al., 2001), 
three divisions were considered, the anteromedial (BNSTam), anterolateral (BNSTal) and 
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posterior (BNSTp). In order to avoid observer bias and to permit comparison between 
groups, the same observer drew all regional boundaries. 
 
Stereological procedures 
Volume and cell number estimations were obtained using StereoInvestigator® software 
(MicroBrightField, Williston, VT, USA) and a motorized microscope (Axioplan 2, Carl Zeiss, 
Hamburg, Germany) attached to a camera (DXC-390, Sony Corporation, Tokyo, Japan). The 
Cavalieri´s principle (Gundersen et al., 1988) was applied to evaluate the volume of each 
region. Average cell numbers were estimated using the optical fractionator method (West et 
al., 1991). Coefficients of error were computed according to previously published formulas 
for cell numbers (Gundersen et al., 1999) and volume estimates (Gundersen and Jensen, 
1987).  Detailed methods are provided in supplementary material. 
 
Dendritic tree analysis 
BLa pyramidal-like, CeA multipolar and BNSTam bipolar neurons were chosen as described 
elsewhere (McDonald, 1982a, b, 1983). For each selected neuron, all branches of the 
dendritic tree were reconstructed at 600x magnification using a motorized microscope 
(Axioplan 2, Carl Zeiss), with oil-immersion objectives, and attached to a camera (DXC-390, 
Sony Corporation) and Neurolucida software (MicroBrightField). A 3-D analysis of the 
reconstructed neurons was performed using NeuroExplorer software (MicroBrightField). 
Dendritic branches were sampled in order to estimate spine density; spines in the selected 
segments were classified in thin, wide, ramified and mushroom categories (Harris et al., 
1992). Thin spines were considered immature, while the other spine types were classified as 
mature. A total of 20 neurons/group/area were drawn (total 120 neurons). 
 
Brain catecholamines 
A different set of males was sacrificed by decapitation (n=6 animals derived from 3 different 
litters per group). After brain snap freezing, macrodissection of the amygdala and bed 
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nucleus of stria terminalis was rapidly performed under a stereomicroscope (Model SZX7, 
Olympus America Inc., Center Valley, PA, USA). Whole brains were placed upside down and, 
using delicate forceps (Dumont #7 forceps, Fine Science Tools USA Inc., Foster City, CA, USA), 
the areas of interest were dissected according to stereological coordinates (Paxinos and 
Watson, 2005). Samples were frozen in liquid nitrogen (overnight at -20ºC) after adding 
percloric acid 0.2M; then, samples were briefly sonicated, centrifuged and 50 µl aliquots of 
the supernatant injected on a high performance liquid chromatography (HPLC) combined 
with electrochemical detection system. A mobile phase of 0.7 M aqueous potassium 
phosphate (monobasic) (pH 3.0) in 10% methanol, 1-heptanesulfonic acid (222 mg/l) and Na-
EDTA (40 mg/l) was used.  
Levels of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-
methoxyphenylacetic acid (homovanillic acid, HVA) were determined using a Gilson 
instrument (Gilson Inc., Middleton, WI, USA), fitted with an analytical column (Supelco 
Supelcosil LC-18 3 M; 7.5 cm x 4.6 mm; flow rate: 1.0–1.5 ml/min; Supelco, Bellefonte, PA, 
USA). A standard curve was then obtained and data presented as concentration (nanogram 
per milligram of tissue protein). 
 
Molecular correlates  
In order to establish molecular correlates, the mRNA expression of dopamine D1 and D2 
receptors (Drd1 and Drd2, respectively) was assessed in the BNST and amygdala. Moreover, 
we evaluated the expression of several synaptic plasticity-related genes, including synapsin 
(Syn), brain-derived neurotrophic factor (BDNF) and neural cell adhesion molecule (NCAM). 
The amygdala and bed nucleus of stria terminalis of an additional set of animals (N=8 
animals derived from 4 different litters/group) were isolated as described above. For Real-
Time PCR analysis, total RNA was isolated from frozen areas using Trizol (Invitrogen) and 
DNase treated (Fermentas), according to manufacturer. Two µg of RNA were converted into 
cDNA using the iSCRIPT kit (Biorad). RT-PCR was performed using SyberGreen (Qiagen) and 
the Biorad q-PCR CFX96 apparatus. HPRT was used as a housekeeping gene. We used relative 
quantification to determine the fold change difference between control and DEX animals, 
Page 44 of 62Psychopharmacology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  10
using the ΔΔCT method as described before (Pfaffl, 2001). Primer sequences available in 
Supplementary Material.  
Statistical analysis 
Results are presented as mean ± SEM. A repeated measures test was used to analyze data 
from acoustic startle, prepulse inhibition and fear potentiated startle; Greenhouse-Geissser 
and Huynh-Feldt´s corrections were applied for acoustic and fear potentiated startle data, 
respectively. The comparison of means between groups was performed using the Student’s 
t-test for the remaining variables. Statistical significance was considered for P<0.05. 
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RESULTS 
Brief antenatal exposure to DEX triggers hyperanxiety and impairs fear conditioning  
Animals exposed to either DEX 1mg/kg or vehicle (controls) at embryonic day 18 and 19 
were tested at 3 months of age. Antenatal exposure to DEX resulted in a significant 
reduction on the ratio of time spent in open arm when compared to controls (t=3.636, 
P=0.004; Figure 1A); these results confirm our previous findings (Oliveira et al., 2006). 
Furthermore, while the number of open arm entries was also decreased following DEX 
exposure (t=2.424, P=0.026; Figure 1B), there were no significant differences between 
groups in the number of closed arm entries (t=0.340, P=0.738), thus showing that the 
increased anxiety behavior should not be attributed to locomotory differences. 
 
In the acoustic startle test, startle amplitudes for DEX exposed subjects increased more 
rapidly as a function of stimulus intensity when compared to controls (F(3,47)=4.036, P=0.016; 
Table 1). When comparing responsiveness to individual noise intensities between groups, 
DEX exposed rats displayed significantly increased startle amplitudes at 70 (t=5.121, 
P<0.001), 80 (t=4.252, P=0.001), 90 (t=3.537, P=0.006), 100 (t=3.045, P=0.012) and 110 dB 
(t=2.452, P=0.025). 
 
Interestingly, the acoustic startle response to inhibitory prepulses was not affected by 
exposure to antenatal DEX, as shown by the analysis of treatment x prepulse intensity 
interaction (F(3,54)=3.858, P=0.994; Figure 2). Moreover, comparison between groups failed 
to reveal significant differences at any prepulse intensity. The fact that all groups had similar 
percentages of reduction in the average of startle response, supports the absence of 
sensorimotor deficits. 
 
Startle amplitude varied as a function of the treatment X stimulus interaction in the fear 
potentiated startle (F(1,18)=8.379; P=0.01; Table 2). While controls displayed enhanced startle 
amplitude after being presented a conditioned stimulus startle, DEX exposure resulted in an 
Page 46 of 62Psychopharmacology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  12
impaired fear conditioning in the acoustic startle, as shown by the significantly decreased 
ratio of conditioned stimulus/basal startle responsiveness in the DEX group (t=-2.602, 
P=0.018; Figure 3). 
 
Antenatal-DEX exposure promotes dendritic remodeling in the BNST and in the amygdala 
To further understand the behavioral findings, we have performed a detailed morphological 
characterization of the BNST and amygdala brain regions, known to be involved in fear and 
anxiety, respectively (Walker and Davis, 1997). 
Volumetric determinations reveal that antenatal exposure to DEX resulted in an increase in 
BNST total volume (t=3.841, P=0.009; data not shown). This effect was largely due to 
increased volumes in anteromedial division of the BNST of DEX-exposed animals (t=5.887, 
P=.001; Figure 4A); conversely, the volumes of BNSTal and BNSTp were not influenced by 
such antenatal exposure (t=-0.484, P=.646 and t=0.718, P=.500, respectively). DEX exposure 
during pregnancy did not affect the total number of cells in the BNST (t=1.595, P=0.162) nor 
in its divisions (BNSTam: t=1.475, P=0.191; BNSTal: t=-1.506, P=0.183; BNSTpost: t=0.946, 
P=0.381; Figure 4B). 
The volumetric increase in the BNST was further scrutinized through a 3-D morphological 
analysis of dendritic arborizations of neurons in the BNSTam; the neurons in this brain region 
were previously described as cells with ovoid soma, moderate polarized dendritic branching, 
with sparse spines (McDonald, 1983). Data revealed that antenatal exposure to DEX resulted 
in a significant increase of total dendritic length when compared to controls (t=4.498, 
P<0.001; Table 3). Spine densities were not affected by antenatal DEX treatment (t=-1.779, 
P=0.085), even when a separate analysis of mature (t=-1.825, P=.076) and immature forms 
(t=-0.534, P=.0596) was performed. 
In contrast to the BNST, antenatal exposure to DEX resulted in a decreased volume of BLa 
and CeA divisions of the amygdala (BLa t=-3.564, P=0.02; CeA t=-3.072, P=0.027) but not in 
the La division (t=-0.561, P=0.605) (Figure 4C). No effect was observed on the estimated 
number of cells in the BLa, CeA and La divisions of the amygdala (t=1.457, P=0.196; t=-1.383, 
P=.216; t=-0.725, P=0.496, respectively; Figure 4D). 
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The analysis of the dendritic arborizations of pyramidal-like neurons in the BLa region of the 
amygdala, which represent the predominant cell-type in the area (70%; type I) (McDonald, 
1982b; Sah et al., 2003), revealed a reduction in total and basal dendritic lengths following 
DEX treatment (t=-2.471, P=0.018 and t=-3.252, P=0.002, respectively; Table 3); however, 
apical dendritic length was not affected (t=-0.832, P=0.411) by antenatal DEX-exposure. The 
density of spines in these neurons was not affected by antenatal exposure to DEX (t=0.165, 
P=0.870), even when assessing mature and immature spines separately (t=-0.122, P=0.903 
and t=0.598, P=0.555, respectively).  
Treatment also affected the CeA predominant cell type, previously called medium spiny 
neurons (by comparison with neurons in the striatum) (Sah et al., 2003). These neurons have 
an ovoid or fusiform soma and three to five nonspiny primary dendrites from which 
moderately spiny, sparsely branching secondary and tertiary dendrites arise. These neurons 
in the DEX progeny displayed a significant dendritic atrophy when compared to controls (t=-
3,491, P=0.002; Table 3). No effect was found on the densities of total, mature and 
immature spines (t=0.435, P=0.666, t=0.023, P=0.982 and t=1.332, P=0.191, respectively). 
 
Neurochemical and molecular correlates 
To complement the behavioral and morphometric analysis, we decided to measure 
dopamine levels and its metabolites. Antenatal DEX exposure had no effect on the 
concentration of dopamine in the BNST, nor its turnover (dopamine t=0.026 P=0.980; 
dopamine turnover t=0.291, P=0.777; Figure 5A-B). 
In contrast, the neurochemical analysis in the amygdala revealed a decrease in dopamine 
concentration following antenatal exposure to DEX (t=5.006, P=0.001; Figure 5C). Moreover, 
dopamine turnover was significantly increased in these subjects (t=-4.405, P=0.001; Figure 
5D).  
At a molecular level, and given the impact of antenatal DEX-exposure on dendritic 
arborization, we assessed the expression of the synaptic plasticity-related genes in the BNST 
and amygdala, namely a synaptic gene (synapsin (Syn)), a neurotrophin (brain-derived 
neurotrophic factor (BDNF)) and a cell adhesion molecule (neural cell adhesion molecule 
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(NCAM)), all known to be involved in synaptic/dendritic plasticy. Moreover, as the 
dopaminergic innervation of the BLa is considered to facilitate amygdala dependent 
functions (Asan, 1997), and since a hypodopaminergic status was previously associated with 
DEX-exposure (Leao et al., 2007; Rodrigues et al., 2010), the expression of dopamine D1 and 
D2 receptors (Drd1 and Drd2, respectively) was also evaluated.  
In the BNST, DEX exposed animals displayed increased expression of synapsin (t=-2.418, 
P=0.030) and NCAM (t=-2.032, P=0.045) (Table 4). No significant differences between groups 
were found in the expression of the remaining genes analysed (Drd1 t=-0.663, P=0.514; Drd2 
t=-0.881, P=0.386; BDNF t=-0.214, P=0.832). 
In the amygdala, Drd2 mRNA levels were significantly increased in the DEX exposed subjects 
(t=-3392, P=0.008), while Drd1 were not affected (t=0.370, P=0.717) (Table 4). The 
expression levels of the synaptic plasticity-related genes, namely synapsin, BDNF and NCAM 
were not significantly different between groups (t=0.546, P=0.594, t=-1.457, P=0.167 and t=-
0.376, P=0.713, respectively).  
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DISCUSSION 
In utero and early postnatal environment, namely the GC milieu, is crucial for 
neurodevelopment not only through its activational effects, but also through important 
programming effects. Increasing evidence suggests that early life exposure to GC triggers 
undesired metabolic, cardiovascular, neuroendocrine and behavioral phenotypes in 
adulthood (Mesquita et al., 2009). Both synthetic (such as DEX) and naturally occurring GCs 
are able to exert a programming effect in the brain; however, it is important to remember 
that their effects can be quite distinct (Oliveira et al., 2006) as endogenous GCs 
preferentially bind to MR, whereas DEX binds almost exclusive to GR (Reul et al., 1987), the 
receptors that mediate most of the detrimental effects of GCs. Although it has been argued 
that synthetic GCs have a limited capacity to reach the brain in mice (De Kloet et al., 1975), 
its deleterious effects in the central nervous system are undeniable (Cerqueira et al., 2005; 
Cerqueira et al., 2007; Leao et al., 2007; McArthur et al., 2005; Yu et al., 2010), specially in 
rats, and may arise from the use of higher dosages which can indeed pass the barriers and 
activate brain GC receptors (Miller et al., 1992; Reul et al., 1987). Moreover, in the context of 
the present study it is important to highlight the fact that the exposure to DEX has occurred 
during a period in which the brain barriers are still immature (Saunders et al., 2000).” 
The data herein presented extends our previous observations that antenatal exposure to 
DEX results in anxiety-like behavior in adult animals (Oliveira et al., 2006). In fact, while we 
confirmed a hyperanxious phenotype in the elevated plus maze, we also found an increased 
acoustic startle response (ASR) in DEX-exposed rats. The startle, a fast protective response 
from the organism to a sudden and intense stimulus (Koch, 1999), is considered an indicator 
of anxiety-like behavior. The ASR results from the activation of a trisynaptic circuit, where 
auditory inputs from several brainstem nuclei (dorsal cochlear nucleus, cochlear root 
nucleus, ventral cochlear nucleus, lateral superior olive and ventrolateral tegmental nucleus) 
are conveyed to a main sensorimotor interface, the caudal pontine reticular nucleus, which 
then projects to spinal motor neurons to trigger the motor response (Koch, 1999; Lee et al., 
1996). Importantly, it was demonstrated that a direct projection from the BNST to the caudal 
pontine reticular nucleus, but also an indirect one via the CeA, are responsible for the 
modulatory response of stressors upon the ASR (Davis et al., 1997). 
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The BNST is one of the relay stations that conveys inputs from stress-sensitive areas of the 
cortex and limbic system both to the HPA axis but also to brain stem nuclei implicated in 
several emotional behaviors (Herman and Cullinan, 1997). Here, we show a hypertrophy of 
the BNST, due to the enlargement of its anteromedial region. Interestingly, this region 
presented alterations in the expression levels of NCAM, a molecule important for neuronal 
plasticity (Bisaz and Sandi, 2010; Nacher et al., 2002). Augmented levels of synapsin, a 
protein involved in the regulation of neurotransmitter release (Rosahl et al., 1995), also 
suggest increased synaptic activity of this brain region in DEX-exposed animals, which is in 
line with the increased dendritic arborization of these animals. Such plastic changes are 
paralleled with an increased startle response, thus supporting the idea of an overactivation 
of this brain subregion. This increased activity of the BNSTam is also in accordance with our 
previous observation of a hyperresponsive HPA axis in these subjects (Oliveira et al., 2006). 
Importantly, the activational increase of circulating corticosteroids might further promote 
the activation of the BNST as it is known that these hormones are implicated in the 
neuroanatomical changes observed in this brain region (Pego et al., 2010). 
Several projections to the caudal pontine reticular nucleus are considered responsible for 
the increase in startle amplitude induced by fear conditioning to a previous neutral stimulus. 
These include projections from the CeA, either direct or via mesencephalic reticular 
formation and deep layers of superior colliculus, but also indirect projections from the 
medial amygdala via ventromedial hypothalamus and ventral periaqueductal gray (Davis, 
2006). Previous data supports that while baseline startle amplitudes are not affected by 
interference with these connections, the response to fear conditioning is. Interestingly, we 
here show that antenatal DEX exposure impairs fear conditioning in adulthood, which is 
consistent with deficits in amygdalar function and memory consolidation for emotionally 
arousing experiences. These results, together with previous data showing that early life 
stress (neonatal isolation) resulted in impairment of context-induced fear conditioning in 
adult male rats (Kosten et al., 2006), confirms that fear conditioning can be modulated by 
adverse early life events. The role of different divisions of the amygdala in fear behavior, in 
particular the CeA and BLa, has been extensively studied. Several forms of CeA lesions have 
been correlated with disruption of fear-potentiated startle (Campeau and Davis, 1995; 
Hitchcock and Davis, 1987; Walker and Davis, 1997). Electrolytic lesions of the CeA 
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completely blocked the expression of fear-potentiated startle in rats (Kim and Davis, 1993). 
Conversely, inactivation of BNST did not disrupt fear-potentiated startle (Gewirtz et al., 
1998; Walker and Davis, 1997); however, more recently, it has been suggested that BNSTlat 
tonically inhibits fear-potentiated startle, probably through projections to the CeA (Meloni 
et al., 2006). Thus, the present observations of decreased volumes in the CeA and BLa in 
DEX-exposed rats are likely to be implicated in the changes in fear conditioning displayed by 
these animals; once again, the volumetric decreases in these amygdalar divisions result 
largely from dendritic atrophy-which fits previous observations of the effects of chronic 
unpredictable stress in the BLa (but not the CeA) (Vyas et al., 2003; Vyas et al., 2002). It is 
relevant to stress at this point that others have shown that a single course of 
betamethasone at postnatal day one failed to affect volumes of cerebral cortex, corpus 
callosum, hippocampus, dentate gyrus or amygdala (Yossuck et al., 2006), however, several 
technical differences may explain this discrepancy. The time of the exposure and the nature 
of insults seems to be critical issues to consider, as several windows of vulnerability to the 
programming effects of different stimuli seem to occur. Indeed, stress effects in neuronal 
morphology of specific brain regions are not necessarily equal across life and depend on the 
type of stress. While stress effects in the BNST morphology seem more similar, since 
different types of stress induce a general hypertrophy of dendrites in the neurons of this 
brain region (Pego et al., 2008; Vyas et al., 2003), the effects of stress in the amygdala are 
less concordant to our present observation of dendritic atrophy. Whereas chronic juvenile 
stress leads to a general hypertrophy of amygdalar dendrites (Eiland et al., 2011), others 
failed to find any significant change in dendritic structure after stress exposure in adulthood 
(Pego et al., 2008) and others have shown remarkably divergent changes in amygdalar 
neurons following different types of stress (Vyas et al., 2003; Vyas et al., 2002). 
Remarkably, such morphological effects in the amygdala were accompanied by changes in 
dopamine but not other cathecolamines levels. Dopamine, arising mainly form the VTA, 
plays a facilitative role in the function of the amygdala (Asan, 1997). In vitro studies also 
suggest that the excitability of amygdalar, namely BLa, neurons is modulated by dopamine 
(Kroner et al., 2005). In addition, behavioral data showed that VTA lesion results in blocked 
fear-potentiated startle (Borowski and Kokkinidis, 1996). At least in part, the facilitation of 
affective behaviors by DA may be explained by actions at the cellular level on BLa neurons. It 
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has been suggested that DA receptor activation could simultaneously facilitate the BLa 
output in response to strong inputs that cause spike firing, while suppressing weaker inputs 
via activation of GABAergic interneurons (Kroner et al., 2005). Thus, the present observation 
of a hypodopaminergic status in the amygdala seems to be of relevance to the deficits in 
fear memory. In fact, it confirms observations in models of dopamine deficient mice (Fadok 
et al., 2010), in which the restoration of dopamine in the BLa was shown to be required for 
the formation of fear-related memory (Fadok et al., 2010). Dopamine levels in the amygdala 
are also determinant for sensorimotor gating, as it was shown that NAcc and amygdalar 
infusions of this neurotransmitter significantly impair PPI (Swerdlow et al., 1992); 
surprisingly, we did not find any differences in PPI in DEX-exposed animals, which is also in 
accordance with another previous study (Hauser et al., 2006). 
Herein, the decreased amygdalar levels of dopamine are associated with increased 
expression of D2 receptor mRNA in DEX exposed subjects; such up-regulation could be seen 
as a compensation mechanism. Remarkably, no differences were found in D1 receptor 
expression, suggesting that D2 receptor has a prominent role in fear behavior. Indeed, while 
D1 receptors may participate in recognition of danger, D2 receptors seem to have a role in 
setting up adaptive responses to adverse stimuli (de la Mora et al., 2010). Moreover, D2 (but 
not D1) antagonists injection in the BLa impairs fear-potentiated startle probably due to 
reduced dopaminergic tone (de Oliveira et al., 2011), which is in agreement with the 
amygdalar hypodopaminergic status seen in DEX-exposed animals. These findings are 
consistent with recent data showing that D2 receptor pathway connecting the VTA and BLa 
modulates conditioned fear (de Oliveira et al., 2011).  
The present findings unravel the impact of antenatal exposure to DEX in the brain regions 
implicated in fear and anxiety behaviors. We show that subjects exposed to GCs during 
neurodevelopment present marked neuroanatomical, neurochemical and molecular 
programming changes in the BNST and amygdala, and are more vulnerable to anxiety and 
fear pathology in adulthood. Thus, our findings further support the concerns raised on the 
potential deleterious effects of antenatal exposure to synthetic corticosteroids (Weinstock 
et al., 2005; Talge et al., 2007; Mesquita et al., 2009) and call for the need of a parsimonious 
use of these drugs. 
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TABLES 
Noise (dB) Controls DEX 
70 dB 30,51 ± 3,03 97,50 ± 15,07 * 
80 dB 32,50 ± 4,72 291,17 ± 86,56 * 
90 dB 145,19 ± 21,39 561,26 ± 115,66 * 
100 dB 1203,54 ± 168,88 3126,46 ± 608,44 * 
110 dB 4645,30 ± 461,93 6221,83 ± 447,09 * 
120 dB 6358,69 ± 257,17 7101,62 ± 519,47 
Table 1 – Acoustic startle data. Startle amplitude (arbitrary units) in response to acoustic 
stimulus. Data presented as mean ± SEM. * different from controls, P<.05. 
 
 Controls DEX 
Startle 5290.89 ± 658.66 5252.08 ± 716.75 
CS + Startle 6229.04 ± 425.83 4554.13 ± 577.61* 
Table 2 – Fear-potentiated acoustic startle data. Startle amplitude (arbitrary units) in 
response to acoustic stimulus with or without previous conditioned stimulus (CS). Data 
presented as mean ± SEM. * different from controls, P<.05. 
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 Controls DEX 
BNSTam (bipolar)   
   Dendritic length (µm) 395 ± 17 511 ± 19* 
   Density of spines (n/µm) 0.58 ± 0.042 0.49 ± 0.027 
      Mature 0.47 ± 0.035 0.39 ± 0.026 
      Immature 0.10 ± 0.015 0.09 ± 0.016 
   
BLa (pyramidal)   
   Dendritic length (µm) 1969 ± 128 1506 ± 137* 
      Basal dendrites 1088 ± 87 721 ± 72* 
      Apical dendrite 881 ± 80 785 ± 83 
   Density of spines (n/µm) 0.95 ± 0.046 0.95 ± 0.027 
      Mature spines 0.71 ± 0.037 0.70 ± 0.026 
      Immature spines 0.24 ± 0.022 0.26 ± 0.012 
   
CeA    
   Dendritic length (µm) 818 ± 38 670 ± 19* 
   Density of spines (n/µm) 0.45 ± 0.043 0.47 ± 0.037 
      Mature 0.35 ± 0.039 0.36 ± 0.032 
      Immature 0.09 ± 0.009 0.12 ± 0.015 
   
Table 3 – Dendritic length and spine density of bipolar neurons of anteromedial region of the 
bed nucleus of stria terminalis (BNSTam), pyramidal-like neurons of basolateral amygdaloid 
nucleus (BLa) and multipolar neurons of the central nucleus of the amygdala (CeA) and Data 
presented as mean ± SEM. * different from controls, P<.05. 
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Treatment Drd1 Drd2 Syn BDNF NCAM 
BNST      
   Controls 0.950 ± 0.12 1.070 ± 0.12 0.918 ± 0.05 1.127 ± 0.14 0.987 ± 0.04 
   DEX 1.229 ± 0.21 1.226 ± 0.13 1.200 ± 0.11* 1.196 ± 0.27 1.318 ± 0.25* 
      
Amygdala      
   Controls 1.066 ± 0.13 0.927 ± 0.07 1.167 ± 0.19 0.920 ± 0.04 1.043 ± 0.10 
   DEX 0.990 ± 0.16 2.494 ± 0.62* 1.060 ± 0.04 1.102 ± 0.12 1.115 ± 0.17 
Table 4 - Gene expression analysis (measured by real-time PCR) in amygdala and bed nucleus 
of stria terminalis (BNST). The mRNA expression levels are presented as the fold change 
increase in relation to the respective control. Data presented as mean ± SEM. * different 
from controls, P<.05. Dopamine D1 receptor (Drd1), dopamine D2 receptor (Drd2), synapsin 
(Syn), brain-derived neurotrophic factor (BDNF) and neural cell adhesion molecule (NCAM).  
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LEGENDS TO FIGURES 
Figure 1 – Elevated plus maze data. (A) Ratio of time spent in open arm over total time. (B) 
Number of open and closed arm entries. Data presented as mean ± SEM. * different from 
controls, P<.05.  
 
Figure 2 – Prepulse inhibition test. Percentages of reduction in average startle response 
compared with startle trials at prepulse intensities of 2, 4, 8 and 16 dB above background 
noise level.  
 
Figure 3 – Fear potentiated acoustic startle data. Data presented as the average of ratios 
between conditioned stimulus/basal startle responsiveness ± SEM. * different from controls, 
P<.05. 
 
Figure 4 – (A) Estimated volumes of anterolateral (BNSTal), anteromedial (BNSTam) and 
posterior (BNSTpost) divisions of the bed nucleus of stria terminalis. Data presented in mm
3
, 
as mean ± SEM. (B) Estimated total number of cells in the anterolateral (BNSTal), 
anteromedial (BNSTam) and posterior (BNSTpost) divisions of the bed nucleus of stria 
terminalis. (C) Estimated volumes of BLa, CeA and La divisions of the amygdala. Data 
presented in mm
3
, as mean ± SEM. (D) Estimated total number of cells in the BLa, CeA and La 
divisions of the amygdala. Data presented as mean ± SEM; * different from controls, P<.05 
 
Figure 5 – Neurochemical analysis by HPLC of the bed nucleus of stria terminalis (BNST) (A-B) 
and the amygdala (C-D). (A, C) Concentration of each neurotransmitter (ng/mg of protein) is 
presented. 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxyphenylacetic 
acid (homovanillic acid, HVA). (B, D) Dopamine turnover assessed by the ratio between 
dopamine metabolites and dopamine concentrations. Data presented as mean ± SEM. 
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